Literature DB >> 24308678

The role of systemic and targeted therapies in brain metastases.

Enrico Franceschi1, Marco Bartolotti, Rosalba Poggi, Monica Di Battista, Dario Palleschi, Alba A Brandes.   

Abstract

For many years, brain metastases (BMs) have been considered as the final stage of a disease course and engendered skepticism about the efficacy of treatments. Local treatments, mainly, whole-brain radiotherapy have been the standard of care, whereas chemotherapy has been considered of limited efficacy due to the potential role of blood-brain barrier.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24308678     DOI： 10.1586/14737140.2014.856760

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


  3 in total

Review 1.  Brain metastases: an overview.

Authors:  F Bertolini; A Spallanzani; A Fontana; R Depenni; G Luppi
Journal:  CNS Oncol       Date:  2015

2.  Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer.

Authors:  Alessandro Russo; Tindara Franchina; Giuseppina Rosaria Rita Ricciardi; Caterina Fanizza; Antonino Scimone; Giuseppe Chiofalo; Antonio Giordano; Vincenzo Adamo
Journal:  Oncotarget       Date:  2017-01-31

Review 3.  A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.

Authors:  Alessandro Russo; Tindara Franchina; Giuseppina Rosaria Rita Ricciardi; Antonio Picone; Giuseppa Ferraro; Mariangela Zanghì; Giuseppe Toscano; Antonio Giordano; Vincenzo Adamo
Journal:  Oncotarget       Date:  2015-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.